Long term treatment of myasthenia gravis with azathioprine
Open Access
- 1 February 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 66 (772) , 102-105
- https://doi.org/10.1136/pgmj.66.772.102
Abstract
Summary: Twenty-seven patients with myasthenia gravis have been treated with azathioprine in conjunction with pyridostigmine and prednisolone for a total of 138 patient years. Side effects necessitated discontinuation of treatment in only four patients. Treatment with azathioprine was associated with marked clinical improvement in all the remaining 23 patients, resulting in reduction in the dose of pyridostigmine and prednisolone. The number of hospital admissions as well as the number of episodes of respiratory failure were markedly reduced.This publication has 15 references indexed in Scilit:
- Portal hypertension secondary to azathioprine in myasthenia gravisPublished by Oxford University Press (OUP) ,1988
- Diaphragmatic myasthenia in mother and childPostgraduate Medical Journal, 1985
- The long term experience of thymectomy for myasthenia gravis.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- Long‐term corticosteriod treatment of myasthenia gravis: Report of 116 PatientsAnnals of Neurology, 1984
- EFFECT OF IMMUNOSUPPRESSIVE DRUGS (AZATHIOPRINE)Annals of the New York Academy of Sciences, 1981
- Controversies about the treatment of myasthenia gravis.Journal of Neurology, Neurosurgery & Psychiatry, 1980
- Function of circulating antibody to acetylcholine receptor in myasthenia gravisNeurology, 1978
- Antibody to acetylcholine receptor in myasthenia gravisNeurology, 1976
- Intrahepatic Cholestasis Due to AzathioprineGastroenterology, 1969
- The Treatment of Severe Myasthenia Gravis with Immunosuppressive AgentsEuropean Neurology, 1969